Cefadroxil Tablets
» Cefadroxil Tablets contain not less than 90.0 percent and not more than 120.0 percent of the labeled amount of C16H17N3O5S.
Packaging and storage— Preserve in tight containers.
Labeling— The Tablets prepared using the hemihydrate form of Cefadroxil are so labeled.
Identification— Mix a quantity of powdered Tablets, equivalent to about 250 mg of cefadroxil, with water to obtain a concentration of about 2 mg of cefadroxil per mL, and filter: the filtrate so obtained responds to Identification test B under Cefadroxil.
Dissolution 711
Medium: water; 900 mL.
Apparatus 2: 50 rpm.
Time: 30 minutes.
Procedure— Determine the amount of C16H17N3O5S dissolved from UV absorbances at the wavelength of maximum absorbance at about 263 nm of filtered portions of the solution under test, suitably diluted with water if necessary, in comparison with a Standard solution having a known concentration of USP Cefadroxil RS in the same medium.
Tolerances— Not less than 75% (Q) of the labeled amount of C16H17N3O5S is dissolved in 30 minutes.
Uniformity of dosage units 905: meet the requirements.
Water, Method I 921: not more than 8.0%.
pH 5.0 Buffer, Mobile phase, Standard preparation, and Chromatographic system Prepare as directed in the Assay under Cefadroxil.
Assay preparation— Weigh and finely powder not fewer than 10 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 200 mg of cefadroxil, to a 200-mL volumetric flask, dilute with pH 5.0 Buffer to volume, and stir by mechanical means for 5 minutes. Use this solution on the day prepared.
Procedure— Proceed as directed for Procedure in the Assay under Cefadroxil. Calculate the quantity, in mg, of C16H17N3O5S in the portion of Tablets taken by the formula:
0.2CE(rU / rS)
in which the terms are as defined therein.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Ahalya Wise, M.S.
(MDANT05) Monograph Development-Antibiotics
Reference Standards Lili Wang, Technical Services Scientist
711 Margareth R.C. Marques, Ph.D.
Senior Scientist
(BPC05) Biopharmaceutics05
USP32–NF27 Page 1821
Chromatographic Column—
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.